Qatar PR Network, Online Press Release from qatar and Doha city
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
WCM-Q Research Reveals Metabolic Processes Underpinning type 2 Diabetes, Retinopathy, Obesity and Dyslipidemia
 
WCM-Q Research Reveals Metabolic Processes Underpinning type 2 Diabetes, Retinopathy, Obesity and Dyslipidemia

Doha – May 19, 2022: Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have identified metabolites that are associated with type 2 diabetes and its complications, mainly obesity, retinopathy and dyslipidemia.

The study, led by Dr. Noha Yousri, Assistant Professor of Research in Genetic Medicine at WCM-Q, analyzed 1,300 metabolites in samples from 996 Qatari adults (57 percent of whom had type 2 diabetes) and 1,159 metabolites from an independent cohort of 2,618 individuals from the Qatar BioBank (11 percent of whom had type 2 diabetes). It identified 373 metabolites associated with type 2 diabetes, obesity, retinopathy, dyslipidemia (measured through lipoprotein levels). A total of 161 of these metabolites were novel, meaning their association with the conditions has never previously been identified. The identified metabolites highlight perturbations in several biological pathways including oxidative stress, lipotoxicity and glucotoxicity, all of which cause dysfunction and damage at cellular level. 

More interestingly, the researchers identified 15 patterns of what they termed “metabo-clinical signatures” based upon clusters of patients with type 2 diabetes who had similar metabolite levels and also shared two or more clinical characteristics, such as obesity, triglyceride, unhealthy HDL/LDL levels, or retinopathy. 

Dr. Yousri explained: “The study of complex diseases as diabetes benefits from profiling metabolites from various metabolic pathways. Being affected by both genetics and the environment, metabolites are useful in deciphering the disease mechanisms. This study gives us new insights into shared metabolic pathways between diabetes and its complications. In addition, the large sample size allowed us to identify disease clusters of individuals with similar complications that are associated with broadly similar metabolic profiles. Identifying such metabo-clinical patterns, and future integration with other omics profiles will enhance personalized medicine approaches for type 2 diabetes, a prevalent disease that affects many people in our region and around the world.”

Type 2 diabetes is a complex disease with many different causes and a wide variety of clinical complications, which makes understanding the disease, and how to treat or prevent it, extremely challenging. To meet this challenge of complexity, WCM-Q uses a highly advanced precision testing platform and powerful computing technology. This allows researchers at WCM-Q to analyze vast quantities of complex data generated from biological samples drawn from very large numbers of individuals. Using this data to build up a ‘disease atlas’ of type 2 diabetes and its complications in this way could potentially provide targets for the development of new drugs and more effective precision medicine approaches. 

Dr. Khalid Fakhro, Chief Research Officer and Director of the Precision Medicine Program at Sidra Medicine, and a senior author of the paper, added: “This study is yet another terrific demonstration of the close collaboration between Sidra Medicine and WCM-Q to characterize the Qatari population on a molecular level. Establishing mutli-omic reference databases based on metabolomics, transcriptomics, genomics and so on, of thousands of Qataris will be key to mapping markers for health and disease in the local population, and of great importance to the Arab world at large.”

The paper, entitled ‘Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia,’ has been published in diabetes, a leading journal. Other researchers who majorly contributed to the paper include Dr. Ronald Crystal of Weill Cornell Medicine in New York, and Dr. Steven Hunt and Dr. Karsten Suhre, both of WCM-Q.

Dr. Khaled Machaca, Senior Associate Dean for Research, Innovations, and Commercialization at WCM-Q, said: “This important study takes a deep dive into the metabolomics of type 2 diabetes and its associated complications, which can be debilitating and distressing for patients and their families. At WCM-Q we are dedicated to using our advanced scientific capabilities to improve our understanding of diseases of importance to the Qatari and local populations in an effort to pave the way for advanced treatments.”

The study was supported by Qatar National Research Fund (a member of the Qatar Foundation) (NPRP11S-0114-180299, NPRP09-740-3-192, and NPRP09-741-3-793), and by Qatar Biobank. The work was also supported by the Bioinformatics Core and Biomedical Research Program in Weill Cornell Medicine-Qatar, funded by the Qatar Foundation.  

Posted by : Qatar and Doha City PR Network Editorial Team
Viewed 10584 times
PR Category : Healthcare & Medicine
Posted on : Friday, May 20, 2022  11:45:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of QatarPRNetwork.com.
Previous Story : QIC Group Holds HMC Blood Donation Campaign
Next Story : WCM-Q Pre-Med Students Explore the Application of Physics in...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Easy 5-Minute Halloween Look with CATRICE! [8238-Views]
Pandora Teams Up with a New Collective of Creatives for Pandora ME [7496-Views]
The Ultimate Halloween Makeup Guide Using Essence Products [6658-Views]
Made To Be Different With Pandora Me [6112-Views]
See the Goal for yourself on Samsung's most Immersive TV Range yet [5525-Views]
Your Autumn/Winter Guide from Essence is Here [5457-Views]
Samsung Showcases Evolution of SmartThings and Introduces New Device Experiences at SDC22 [5256-Views]
Pandora Launch a New Limited-Edition Charm in Support of UNICEF Giving Young Voices the Chance to Th... [4975-Views]
LG Announces Third-Quarter 2022 Financial Results [4962-Views]
Fall in Love with Catrice [4791-Views]
Ajmal Perfumes Launches New Qafiya 07 And Qafiya 08 [4668-Views]
When It's Filled with Love and Meaning, It's More than a Gift [4204-Views]
Ogilvy Celebrates a giant performance at this year's LIA's – Including awards for Global Network of... [3867-Views]
Amber Lounge Makes Its Grand Debut in Doha for the World's Biggest Sporting Event [3208-Views]
Football Fans on Epic ‘Electric Car to Qatar' trip, supported by MG [1909-Views]
KnowTalks 2022 discuss ‘Enabling the Private Sector's Participation in Development' and ‘Bioinformat... [1907-Views]
Hublot Reveals the Big Bang e Qatar Edition [1589-Views]
What a shot! David Beckham Snaps a Scenic View as Qatar Tourism unveils Posts of Qatar [1502-Views]
The Impact of Science Communication on Health Education and Public Engagement [1390-Views]
Hotpack Launches Own Manufacturing Plant in Qatar [1367-Views]
 
RSS Facebook Twitter LinkedDin QatarPRNetwork.com on Instagram
 
Top Sections
 
Top Stories